NCT00526578

Brief Summary

The goal of this research study is to investigate the role of genes that may point to a higher risk of developing pancreatic cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,770

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2002

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2007

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 10, 2007

Completed
17.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

January 6, 2020

Status Verified

January 1, 2020

Enrollment Period

23 years

First QC Date

September 5, 2007

Last Update Submit

January 3, 2020

Conditions

Pancreatic Cancer

Keywords

Pancreatic CancerPancreatic Cancer Genetic EpidemiologyPACGENEHealthy ControlFamilial Pancreatic CancerFPCQuestionnaire

Outcome Measures

Primary Outcomes (1)

  • Identification of susceptibility genes in high risk familial pancreatic cancer (FPC) pedigrees using cutting-edge genetic analysis methods

    Data collection from patient response to 30-40 minute questionnaire and blood test.

    8 Years

Study Arms (1)

Questionnaire

Pancreatic cancer patients or family member.

Behavioral: Questionnaire

Interventions

QuestionnaireBEHAVIORAL

Questionnaire taking about 30-40 minutes to complete.

Also known as: Survey
Questionnaire

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MDACC pancreatic cancer patients and family members (two or more) of someone with pancreatic cancer, all over over the age of 18.

You may qualify if:

  • \) An effected or uneffected member of a family, age 18 or older, that has two or more reported pancreatic cancers in the family.

You may not qualify if:

  • Cases under age 18.
  • Relatives of pancreatic cancer cases under age 18.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Blood sample will be collected.

MeSH Terms

Conditions

Pancreatic NeoplasmsPancreatic carcinoma, familial

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Carrie Daniel-MacDougall, PHD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2007

First Posted

September 10, 2007

Study Start

June 19, 2002

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

January 6, 2020

Record last verified: 2020-01

Locations

US(1)